Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells1

Cancer Research

Volumn 57, Issue 14, 1997, Pages 3046-3054

  Smith, Leia M ^a,d   Birrer, Michael J ^a   Stampfer, Martha R ^b   Brown, Powel H ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SURAMIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION;

BREAST; BREAST NEOPLASMS; CELL LINE; EPIDERMAL GROWTH FACTOR; EPITHELIUM; FEMALE; GENES, FOS; GENES, JUN; HUMANS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 1842339278     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Dickson, R. B., and Lippman, M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev., 8: 29-43, 1987.
2. Stampfer, M. R., and Yaswen, P. Factors influencing growth and differentiation of normal and transformed human mammary epithelial cells in culture. In: G. E. Milo, B. C. Castro, and C. F. Shuler (eds.), Transformation of Human Epithelial Cells: Molecular and Oncogenetic Mechanisms, pp. 117-140. Boca Raton: CRC Press, Inc., 1992.
3. Callahan, R., and Salomon, D. S. Oncogenes, tumour suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy. Cancer Surv., 18: 35-56, 1993.
4. Mane, B. M., Jeschke, M., Graus-Porta, D., Taverna, D., Hofer, P., Groner, B., Yarden, Y., and Hynes, N. E. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Mol. Endocrinol., 9: 14-23, 1995.
5. Van der Berg, B., De Groot, R. P., Isbrucker, L., Kruijer, W., and De Laat, S. W. Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells. J. Steroid Biochem. Mol. Biol., 43: 111-115, 1992.
6. Van der Burg, B., De Groot, R. P., Isbrucker, L., Kruijer, W., and DeLaat, S. Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells. J. Steroid Biochem. Mol. Biol., 40: 215-221, 1991.
7. Krywicki, R., and Yee, D. The insulin-like growth factor family of ligands, receptors, and binding proteins. Breast Cancer Res. Treat., 22: 7-19, 1992.
8. Lotan, R. Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res., 39: 1014-1019, 1979.
9. Lotan, R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim. Biophys. Acta. 605: 33-91, 1980.
10. Kaplan, D., Perkins, A., and Morrison, D. K. Oncogenes and Tumor Suppressor Genes in Human Malignancies, pp. 265-279. Boston: Kluwer, 1993.
11. Holt, J. Oncogenes and Tumor Suppressor Genes in Human Malignancies, pp. 301-311. Boston: Kluwer Academic Publishers, 1993.
12. Angel, P., and Karin, M. The role of Jun. Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072: 129-157, 1991.
13. Halazonetis, T. D., Georgopoulos, K., Greenberg, M. E., and Leder, P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell, 55: 917-924, 1988.
14. Chiu, R., Angel, P., and Karin, M. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell, 59: 979-986, 1989.
15. Schutte, J., Viallet, J., Nau, M., Segal, S., Fedorko, J., and Minna, J. Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell, 59: 987-997, 1989.
16. Ryseck, R. P., and Bravo, R. c-JUN, JUN B. and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene, 6: 533-542, 1991.
17. Nakabeppu, Y., and Nathans, D. A naturally occurring truncated form of fosB that inhibits fos/jun transcriptional activity. Cell, 64: 751-759, 1991.
18. Pfarr, C. M. Mechta, F., Spyrou, G., Lallemand, D., Carillo, S., and Yaniv, M. Mouse JunD negatively regulales fibroblast growth and antagonizes transformation by ras. Cell, 76: 747-760, 1994.
19. Bravo, R., Burckhardt, J., Curran, T., and Muller, R. Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J., 4: 1193-1197, 1985.
20. Curran, T., Bravo, R., and Muller, R. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation. Cancer Surv., 4: 655-681, 1985.
21. Buscher, M., Rahmsdorf, H. J., Litfin, M., Karin, M., and Herrlich, P. Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene, 3: 301-311, 1988.
22. Lamph, W. W., Wamsley, P., Sassone, C. P., and Verma, I. M. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature (Lond.), 334: 629-631, 1988.
23. Szabo, E., Preis, L. H., Brown, P. H., and Birrer, M. J. The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acctaie induced hemopoietic differentiation. Cell Growth & Differ., 2: 475-482, 1991.
24. Benbrook, D. M., and Jones, N. C. Heterodimer formation between CREB and JUN proteins. Oncogene, 5: 295-302, 1990.
25. Stein, B., Baldwin, A. S., Jr., Ballard, D. W., Greene, W. C., Angel, P., and Herrlich, P. Cross-coupling of the NFkB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J., 12: 3879-3891, 1993.
26. Pfahl, M. Nuclear receptors/AP-1 interaction. Endocr. Rev., 14: 651-658, 1993.
27. Chen, T. K., Smith, L. M., Gebhardt, D. K., Birrer, M. J., and Brown, P. H. Activation and inhibition of the AP-1 complex in human breast cancer cells. Mol. Carcinog., 15, 215-226, 1996.
28. Stampfer, M. R., and Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA, 82: 2394-2398, 1985.
29. Stampfer, M., Hallowes, R. C., and Hackett, A. J. Growth of normal human mammary epithelial cells in culture. In Vitro. 16: 415-425, 1980.
30. Walen, K., and Stampfer, M. R. Chromosome analyses of human mammary epithelial cells at stages of chemically-induced transformalion progression to immortality. Cancer Genet. Cytogenet., 37: 249-261, 1989.
31. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Bienz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF10. Cancer Res., 50: 6075-6086, 1990.
32. Tait, E., Soule, H. D., and Russo, J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF10. Cancer Res., 50: 6087-6094, 1990.
33. Basolo, F., Elliot, J., Tait, L., Chen, X. Q., Maloney, T., Russo, I. H., Pauley, R., Momiki, S., Caamano, J., Klein-Szanto, A. J. P., Koszalka, M., and Russo, J. Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol. Carcinog., 4: 25-35, 1991.
34. Bates, S. E., Valverius, E. M., Ennis, B. W., Bronzert, D. A., Sheridan, J. P., Stampfer, M. R., Mendelsohn, J., Lippman, M. E., and Dickson, R. B. Expression of the transforming growth factor-α/epidermal growth factor receptor pathway in normal human breast epithelial cells. Endocrinology. 126: 596-607, 1990.
35. Valverius, E., Bates, S. E., Stampfer, M. R., Clark, R., McCormick, F., Salomon, D. S., Lippman, M. E., and Dickson, R. B. Transforming growth factor α production and EGF receptor expression in normal and oncogene transformed human mammary epithelial cells. Mol. Endocrinol., 3: 203-214, 1989.
36. Stampfer, M. R., Pan, C. H., Hosoda, J., Bartolomew, J., Mendelsohn, J., and Yaswen, P. Blockade of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. Exp. Cell Res., 208: 175-188, 1993.
37. Foekens, J. A., Sieuwerts, A. M., Stuurman-Smeets, E. M. J., Dorssers, L. C. J., Berns, E. M. J. J., and Klijn, J. G. M. Pleiotropic actions of suramin on the proliferation of human breast cancer cells in vitro. Int. J. Cancer. 51: 439-444, 1992.
38. Schontal, A., Herrlich, P., Rahmsdorf, H. J., and Ponta, H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell. 54: 325-334, 1988.
39. Wasylyk, C., Wasylyk, B., Heidecker, G., Huleihel, M., and Rapp, U. R. Expression of raf oncogenes activates the PEA1 transcription factor motif. Mol. Cell. Biol., 9: 2247-2250, 1989.
40. Sistonen, L., Holtta, E., Lehvaslaiho, H., Lehtola, E., and Alitalo, K. J. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase. J. Cell. Biol., 109: 1911-1919, 1989.
41. Binetruy, B., Smeal, T., and Karin, M. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature (Lond.), 351: 122-127, 1991.
42. Yoshioka, K., Deng, T., Cavigelli, M., and Karin, M. Amitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc. Natl. Acad. Sci. USA, 92: 4972-4976, 1995.
43. Dong, Z., Birrer, M. J., Watts, R. G., Matrisian, L. M., and Colburn, N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. USA. 91: 609-613, 1994.
44. Domann, F. E., Jr., Levy, J. P., Finch, J. S., and Bowden, G. T. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol. Carcinog., 9: 61-66, 1994.
45. Osborne, C. K., Hamilton, B., Nover, M., and Ziegler, J. Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells. J. Clin. Invest., 67: 943-951, 1981.
46. Darbon, J-M., Valette, A., and Bayard, F. Phorbol esters inhibit the proliferation of MCF-7 cells. Biochem. Pharmacol., 35: 2683-2686, 1986.
47. Yamit-Hezi, A., Plaksin, D., and Eisenbach, L. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression. Oncogene. 9: 1065-1079, 1994.
48. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. Environmental stresses signal apoptosis through a ceramide-initiated SAPK/JNK-mediated cascade. Nature (Lond.), 380: 75-79, 1996.
49. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington DC), 270: 1326-1331, 1995.
50. Kerppola, T. K., and Curran, T. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. Oncogene, 9: 675-684, 1994.
51. Kataoku, K., Noda, M., and Nishizawa, M. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos, and small Maf proteins. Oncogene, 12: 53-62, 1996.